David Pawsat
Public Health & General Preventive Medicine East Lansing, MI Doctor of Osteopathy
NPI 1568476075 CMS profile 607009
1520 Ramblewood Dr., Suite 100, East Lansing, MI 48823
General payments
$271
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, David Pawsat of East Lansing, MI is reported in the CMS Open Payments database as having received $271 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 68th percentile of Public Health & General Preventive Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $271 | 1 |
Beside peers
- David Pawsat
- Public Health & General Preventive Medicine median
- Middle half of Public Health & General Preventive Medicine
- National median
In program year 2025, general payments to David Pawsat were reported at $0. Among 185 Public Health & General Preventive Medicine profiles paid that year, the median was $99 and the middle half received between $32 and $365.
Show as a table
| Year | David Pawsat | Public Health & General Preventive Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $99 | $22–$287 | $163 |
| 2020 | $0 | $101 | $21–$478 | $114 |
| 2021 | $0 | $99 | $31–$856 | $132 |
| 2022 | $271 | $79 | $24–$340 | $149 |
| 2023 | $0 | $102 | $28–$326 | $160 |
| 2024 | $0 | $98 | $27–$291 | $164 |
| 2025 | $0 | $99 | $32–$365 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
55
Drug cost
$916
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 55 | $916 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 584 Part D prescribers listed as Preventive Medicine; they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Public Health & General Preventive Medicine in Michigan
Edward Rosick
Public Health & General Preventive Medicine · East Lansing, MI
Trissa Torres
Public Health & General Preventive Medicine · Grand Blanc, MI
Janet Greenhut
Public Health & General Preventive Medicine · Ann Arbor, MI
Irvin Gastman
Public Health & General Preventive Medicine · Detroit, MI
Diana Torres-Burgos
Public Health & General Preventive Medicine · Ypsilanti, MI
David Share
Public Health & General Preventive Medicine · Ypsilanti, MI
Related records
Public Health & General Preventive Medicine in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Public Health & General Preventive Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.